nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—kidney cancer	0.445	0.636	CbGaD
Ketorolac—PTGS2—kidney cancer	0.254	0.364	CbGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00174	0.0627	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00138	0.0498	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—kidney cancer	0.00105	0.0378	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT8—kidney cancer	0.000927	0.0334	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.000915	0.0329	CbGpPWpGaD
Ketorolac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—kidney cancer	0.000768	0.0276	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.000727	0.0262	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOSL1—kidney cancer	0.000719	0.0259	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—PTGS1—kidney cancer	0.000601	0.0216	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS1—kidney cancer	0.000591	0.0997	CrCbGaD
Ketorolac—Nepafenac—PTGS1—kidney cancer	0.000562	0.0949	CrCbGaD
Ketorolac—Fenbufen—PTGS1—kidney cancer	0.000538	0.0907	CrCbGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.000516	0.0186	CbGpPWpGaD
Ketorolac—PTGS2—Eicosanoid Synthesis—PTGS1—kidney cancer	0.000499	0.018	CbGpPWpGaD
Ketorolac—Mebendazole—CYP1A1—kidney cancer	0.000482	0.0813	CrCbGaD
Ketorolac—Tolmetin—PTGS1—kidney cancer	0.000467	0.0788	CrCbGaD
Ketorolac—Salsalate—PTGS1—kidney cancer	0.000467	0.0788	CrCbGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOSL1—kidney cancer	0.000465	0.0167	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—ROS1—kidney cancer	0.000462	0.0166	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—kidney cancer	0.000453	0.0163	CbGpPWpGaD
Ketorolac—Suprofen—PTGS1—kidney cancer	0.000448	0.0756	CrCbGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000444	0.016	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—ACY1—kidney cancer	0.000431	0.0155	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.000417	0.015	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.000409	0.0147	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—EIF4EBP1—kidney cancer	0.000389	0.014	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—HSPB1—kidney cancer	0.000389	0.014	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—kidney cancer	0.000378	0.0136	CbGpPWpGaD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—kidney cancer	0.000371	0.0133	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS2—kidney cancer	0.000338	0.057	CrCbGaD
Ketorolac—PTGS2—S1P1 pathway—KDR—kidney cancer	0.00033	0.0119	CbGpPWpGaD
Ketorolac—Nepafenac—PTGS2—kidney cancer	0.000321	0.0542	CrCbGaD
Ketorolac—Fenbufen—PTGS2—kidney cancer	0.000307	0.0519	CrCbGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTGS2—kidney cancer	0.00029	0.0105	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000277	0.00998	CbGpPWpGaD
Ketorolac—Salsalate—PTGS2—kidney cancer	0.000267	0.0451	CrCbGaD
Ketorolac—Tolmetin—PTGS2—kidney cancer	0.000267	0.0451	CrCbGaD
Ketorolac—Mebendazole—ABCB1—kidney cancer	0.000256	0.0432	CrCbGaD
Ketorolac—Suprofen—PTGS2—kidney cancer	0.000256	0.0432	CrCbGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—kidney cancer	0.000244	0.00879	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CD34—kidney cancer	0.000242	0.0087	CbGpPWpGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGS2—kidney cancer	0.000241	0.00867	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—kidney cancer	0.000238	0.00858	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—ALDH1A1—kidney cancer	0.000236	0.0085	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR1—kidney cancer	0.000228	0.00822	CbGpPWpGaD
Ketorolac—Ketoprofen—PTGS1—kidney cancer	0.000228	0.0385	CrCbGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000225	0.0081	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000225	0.00808	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—kidney cancer	0.000208	0.0075	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.000201	0.00725	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000191	0.00688	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—kidney cancer	0.000182	0.00653	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000179	0.00643	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000178	0.00642	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PTGS1—kidney cancer	0.000176	0.00635	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—MAPK3—kidney cancer	0.000172	0.00618	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—MAPK1—kidney cancer	0.000163	0.00588	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.000158	0.00568	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000158	0.00568	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—kidney cancer	0.000152	0.00548	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	0.000152	0.00546	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—kidney cancer	0.000148	0.00533	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTT1—kidney cancer	0.000139	0.00499	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—ANXA1—kidney cancer	0.000137	0.00493	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000134	0.00482	CbGpPWpGaD
Ketorolac—Ketoprofen—PTGS2—kidney cancer	0.00013	0.022	CrCbGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.000127	0.00459	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	0.000124	0.00448	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000123	0.00442	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000123	0.00442	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	0.00012	0.00433	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000118	0.00423	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000117	0.00423	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000117	0.00421	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000116	0.00419	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	0.000115	0.00414	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000115	0.00413	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000108	0.00387	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000101	0.00365	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	9.85e-05	0.00355	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTP1—kidney cancer	9.62e-05	0.00346	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	9.58e-05	0.00345	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	9.31e-05	0.00335	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	9.24e-05	0.00333	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.11e-05	0.00328	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.95e-05	0.00322	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTM1—kidney cancer	8.84e-05	0.00318	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	8.77e-05	0.00316	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	8.52e-05	0.00307	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	8.41e-05	0.00303	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP1A1—kidney cancer	8.38e-05	0.00302	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	8.36e-05	0.00301	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	8.36e-05	0.00301	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	8.23e-05	0.00296	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	8.05e-05	0.0029	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	7.82e-05	0.00281	CbGpPWpGaD
Ketorolac—Blood creatinine increased—Doxorubicin—kidney cancer	7.79e-05	0.000292	CcSEcCtD
Ketorolac—Malnutrition—Capecitabine—kidney cancer	7.77e-05	0.000291	CcSEcCtD
Ketorolac—Erythema—Capecitabine—kidney cancer	7.77e-05	0.000291	CcSEcCtD
Ketorolac—Oedema—Paclitaxel—kidney cancer	7.73e-05	0.00029	CcSEcCtD
Ketorolac—Anaphylactic shock—Paclitaxel—kidney cancer	7.73e-05	0.00029	CcSEcCtD
Ketorolac—Body temperature increased—Vincristine—kidney cancer	7.69e-05	0.000288	CcSEcCtD
Ketorolac—Abdominal pain—Vincristine—kidney cancer	7.69e-05	0.000288	CcSEcCtD
Ketorolac—Liver function test abnormal—Doxorubicin—kidney cancer	7.68e-05	0.000288	CcSEcCtD
Ketorolac—Infection—Paclitaxel—kidney cancer	7.68e-05	0.000288	CcSEcCtD
Ketorolac—Flatulence—Capecitabine—kidney cancer	7.66e-05	0.000287	CcSEcCtD
Ketorolac—Dysgeusia—Capecitabine—kidney cancer	7.61e-05	0.000285	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	7.61e-05	0.00274	CbGpPWpGaD
Ketorolac—Dizziness—Sunitinib—kidney cancer	7.61e-05	0.000285	CcSEcCtD
Ketorolac—Feeling abnormal—Gemcitabine—kidney cancer	7.61e-05	0.000285	CcSEcCtD
Ketorolac—Shock—Paclitaxel—kidney cancer	7.6e-05	0.000285	CcSEcCtD
Ketorolac—Vomiting—Sorafenib—kidney cancer	7.6e-05	0.000285	CcSEcCtD
Ketorolac—Abdominal pain upper—Doxorubicin—kidney cancer	7.6e-05	0.000285	CcSEcCtD
Ketorolac—Nervous system disorder—Paclitaxel—kidney cancer	7.58e-05	0.000284	CcSEcCtD
Ketorolac—Hypokalaemia—Doxorubicin—kidney cancer	7.57e-05	0.000284	CcSEcCtD
Ketorolac—Thrombocytopenia—Paclitaxel—kidney cancer	7.57e-05	0.000284	CcSEcCtD
Ketorolac—Tachycardia—Paclitaxel—kidney cancer	7.54e-05	0.000283	CcSEcCtD
Ketorolac—Rash—Sorafenib—kidney cancer	7.54e-05	0.000283	CcSEcCtD
Ketorolac—Dermatitis—Sorafenib—kidney cancer	7.53e-05	0.000282	CcSEcCtD
Ketorolac—Back pain—Capecitabine—kidney cancer	7.52e-05	0.000282	CcSEcCtD
Ketorolac—Breast disorder—Doxorubicin—kidney cancer	7.52e-05	0.000282	CcSEcCtD
Ketorolac—Skin disorder—Paclitaxel—kidney cancer	7.51e-05	0.000282	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	7.5e-05	0.0027	CbGpPWpGaD
Ketorolac—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	7.49e-05	0.000281	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	7.49e-05	0.000281	CcSEcCtD
Ketorolac—Headache—Sorafenib—kidney cancer	7.49e-05	0.000281	CcSEcCtD
Ketorolac—Hyperhidrosis—Paclitaxel—kidney cancer	7.47e-05	0.00028	CcSEcCtD
Ketorolac—Diarrhoea—Dactinomycin—kidney cancer	7.45e-05	0.000279	CcSEcCtD
Ketorolac—Nasopharyngitis—Doxorubicin—kidney cancer	7.44e-05	0.000279	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ACY1—kidney cancer	7.37e-05	0.00265	CbGpPWpGaD
Ketorolac—Anorexia—Paclitaxel—kidney cancer	7.37e-05	0.000276	CcSEcCtD
Ketorolac—Gastritis—Doxorubicin—kidney cancer	7.36e-05	0.000276	CcSEcCtD
Ketorolac—Vision blurred—Capecitabine—kidney cancer	7.32e-05	0.000275	CcSEcCtD
Ketorolac—Vomiting—Sunitinib—kidney cancer	7.31e-05	0.000274	CcSEcCtD
Ketorolac—Body temperature increased—Gemcitabine—kidney cancer	7.3e-05	0.000274	CcSEcCtD
Ketorolac—Tremor—Capecitabine—kidney cancer	7.28e-05	0.000273	CcSEcCtD
Ketorolac—Rash—Sunitinib—kidney cancer	7.25e-05	0.000272	CcSEcCtD
Ketorolac—Dermatitis—Sunitinib—kidney cancer	7.25e-05	0.000272	CcSEcCtD
Ketorolac—Abdominal distension—Doxorubicin—kidney cancer	7.24e-05	0.000271	CcSEcCtD
Ketorolac—Hypotension—Paclitaxel—kidney cancer	7.22e-05	0.000271	CcSEcCtD
Ketorolac—Ill-defined disorder—Capecitabine—kidney cancer	7.21e-05	0.00027	CcSEcCtD
Ketorolac—Headache—Sunitinib—kidney cancer	7.21e-05	0.00027	CcSEcCtD
Ketorolac—Asthma—Doxorubicin—kidney cancer	7.19e-05	0.00027	CcSEcCtD
Ketorolac—Anaemia—Capecitabine—kidney cancer	7.18e-05	0.000269	CcSEcCtD
Ketorolac—Hypersensitivity—Vincristine—kidney cancer	7.17e-05	0.000269	CcSEcCtD
Ketorolac—Eosinophilia—Doxorubicin—kidney cancer	7.12e-05	0.000267	CcSEcCtD
Ketorolac—Nausea—Sorafenib—kidney cancer	7.1e-05	0.000266	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	7.07e-05	0.00254	CbGpPWpGaD
Ketorolac—Pancreatitis—Doxorubicin—kidney cancer	7.05e-05	0.000264	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.04e-05	0.000264	CcSEcCtD
Ketorolac—Malaise—Capecitabine—kidney cancer	7.01e-05	0.000263	CcSEcCtD
Ketorolac—Insomnia—Paclitaxel—kidney cancer	6.99e-05	0.000262	CcSEcCtD
Ketorolac—Vertigo—Capecitabine—kidney cancer	6.98e-05	0.000262	CcSEcCtD
Ketorolac—Asthenia—Vincristine—kidney cancer	6.98e-05	0.000262	CcSEcCtD
Ketorolac—Syncope—Capecitabine—kidney cancer	6.97e-05	0.000261	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	6.96e-05	0.0025	CbGpPWpGaD
Ketorolac—Leukopenia—Capecitabine—kidney cancer	6.96e-05	0.000261	CcSEcCtD
Ketorolac—Paraesthesia—Paclitaxel—kidney cancer	6.94e-05	0.00026	CcSEcCtD
Ketorolac—Vomiting—Dactinomycin—kidney cancer	6.92e-05	0.00026	CcSEcCtD
Ketorolac—Dyspnoea—Paclitaxel—kidney cancer	6.89e-05	0.000258	CcSEcCtD
Ketorolac—Somnolence—Paclitaxel—kidney cancer	6.87e-05	0.000258	CcSEcCtD
Ketorolac—Palpitations—Capecitabine—kidney cancer	6.87e-05	0.000258	CcSEcCtD
Ketorolac—Rash—Dactinomycin—kidney cancer	6.87e-05	0.000258	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	6.86e-05	0.00247	CbGpPWpGaD
Ketorolac—Nausea—Sunitinib—kidney cancer	6.83e-05	0.000256	CcSEcCtD
Ketorolac—Loss of consciousness—Capecitabine—kidney cancer	6.83e-05	0.000256	CcSEcCtD
Ketorolac—Pancytopenia—Doxorubicin—kidney cancer	6.83e-05	0.000256	CcSEcCtD
Ketorolac—Dyspepsia—Paclitaxel—kidney cancer	6.8e-05	0.000255	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	6.8e-05	0.00245	CbGpPWpGaD
Ketorolac—Cough—Capecitabine—kidney cancer	6.78e-05	0.000254	CcSEcCtD
Ketorolac—Dysuria—Doxorubicin—kidney cancer	6.72e-05	0.000252	CcSEcCtD
Ketorolac—Decreased appetite—Paclitaxel—kidney cancer	6.72e-05	0.000252	CcSEcCtD
Ketorolac—Hypertension—Capecitabine—kidney cancer	6.71e-05	0.000252	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.67e-05	0.00025	CcSEcCtD
Ketorolac—Fatigue—Paclitaxel—kidney cancer	6.66e-05	0.00025	CcSEcCtD
Ketorolac—Diarrhoea—Vincristine—kidney cancer	6.66e-05	0.00025	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	6.65e-05	0.00239	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	6.65e-05	0.00239	CbGpPWpGaD
Ketorolac—Pollakiuria—Doxorubicin—kidney cancer	6.64e-05	0.000249	CcSEcCtD
Ketorolac—Asthenia—Gemcitabine—kidney cancer	6.62e-05	0.000248	CcSEcCtD
Ketorolac—Myalgia—Capecitabine—kidney cancer	6.62e-05	0.000248	CcSEcCtD
Ketorolac—Arthralgia—Capecitabine—kidney cancer	6.62e-05	0.000248	CcSEcCtD
Ketorolac—Chest pain—Capecitabine—kidney cancer	6.62e-05	0.000248	CcSEcCtD
Ketorolac—Pain—Paclitaxel—kidney cancer	6.61e-05	0.000248	CcSEcCtD
Ketorolac—Constipation—Paclitaxel—kidney cancer	6.61e-05	0.000248	CcSEcCtD
Ketorolac—Anxiety—Capecitabine—kidney cancer	6.59e-05	0.000247	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.57e-05	0.000246	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—kidney cancer	6.56e-05	0.000246	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—kidney cancer	6.54e-05	0.000245	CcSEcCtD
Ketorolac—Discomfort—Capecitabine—kidney cancer	6.54e-05	0.000245	CcSEcCtD
Ketorolac—Pruritus—Gemcitabine—kidney cancer	6.53e-05	0.000245	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—kidney cancer	6.48e-05	0.000243	CcSEcCtD
Ketorolac—Dry mouth—Capecitabine—kidney cancer	6.47e-05	0.000243	CcSEcCtD
Ketorolac—Nausea—Dactinomycin—kidney cancer	6.47e-05	0.000243	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—kidney cancer	6.45e-05	0.000242	CcSEcCtD
Ketorolac—Dizziness—Vincristine—kidney cancer	6.43e-05	0.000241	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—kidney cancer	6.41e-05	0.00024	CcSEcCtD
Ketorolac—Confusional state—Capecitabine—kidney cancer	6.39e-05	0.00024	CcSEcCtD
Ketorolac—Feeling abnormal—Paclitaxel—kidney cancer	6.37e-05	0.000239	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.35e-05	0.000238	CcSEcCtD
Ketorolac—Oedema—Capecitabine—kidney cancer	6.34e-05	0.000238	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	6.34e-05	0.00228	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Paclitaxel—kidney cancer	6.32e-05	0.000237	CcSEcCtD
Ketorolac—Diarrhoea—Gemcitabine—kidney cancer	6.32e-05	0.000237	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—kidney cancer	6.3e-05	0.000236	CcSEcCtD
Ketorolac—Infection—Capecitabine—kidney cancer	6.3e-05	0.000236	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.28e-05	0.00226	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PDHB—kidney cancer	6.27e-05	0.00226	CbGpPWpGaD
Ketorolac—Stomatitis—Doxorubicin—kidney cancer	6.25e-05	0.000234	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—kidney cancer	6.25e-05	0.000234	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—POMC—kidney cancer	6.25e-05	0.00225	CbGpPWpGaD
Ketorolac—Shock—Capecitabine—kidney cancer	6.24e-05	0.000234	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—kidney cancer	6.23e-05	0.000234	CcSEcCtD
Ketorolac—Nervous system disorder—Capecitabine—kidney cancer	6.22e-05	0.000233	CcSEcCtD
Ketorolac—Thrombocytopenia—Capecitabine—kidney cancer	6.21e-05	0.000233	CcSEcCtD
Ketorolac—Tachycardia—Capecitabine—kidney cancer	6.19e-05	0.000232	CcSEcCtD
Ketorolac—Vomiting—Vincristine—kidney cancer	6.19e-05	0.000232	CcSEcCtD
Ketorolac—Skin disorder—Capecitabine—kidney cancer	6.16e-05	0.000231	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—kidney cancer	6.14e-05	0.00023	CcSEcCtD
Ketorolac—Urticaria—Paclitaxel—kidney cancer	6.14e-05	0.00023	CcSEcCtD
Ketorolac—Rash—Vincristine—kidney cancer	6.13e-05	0.00023	CcSEcCtD
Ketorolac—Hyperhidrosis—Capecitabine—kidney cancer	6.13e-05	0.00023	CcSEcCtD
Ketorolac—Dermatitis—Vincristine—kidney cancer	6.13e-05	0.00023	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—kidney cancer	6.11e-05	0.000229	CcSEcCtD
Ketorolac—Body temperature increased—Paclitaxel—kidney cancer	6.11e-05	0.000229	CcSEcCtD
Ketorolac—Abdominal pain—Paclitaxel—kidney cancer	6.11e-05	0.000229	CcSEcCtD
Ketorolac—Headache—Vincristine—kidney cancer	6.1e-05	0.000229	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—kidney cancer	6.06e-05	0.000227	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—kidney cancer	6.05e-05	0.000227	CcSEcCtD
Ketorolac—Anorexia—Capecitabine—kidney cancer	6.04e-05	0.000227	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—kidney cancer	5.98e-05	0.000224	CcSEcCtD
Ketorolac—Hypotension—Capecitabine—kidney cancer	5.93e-05	0.000222	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CCBL1—kidney cancer	5.89e-05	0.00212	CbGpPWpGaD
Ketorolac—Vomiting—Gemcitabine—kidney cancer	5.87e-05	0.00022	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—kidney cancer	5.86e-05	0.00022	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ACY1—kidney cancer	5.85e-05	0.00211	CbGpPWpGaD
Ketorolac—Rash—Gemcitabine—kidney cancer	5.82e-05	0.000218	CcSEcCtD
Ketorolac—Dermatitis—Gemcitabine—kidney cancer	5.81e-05	0.000218	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—kidney cancer	5.78e-05	0.000217	CcSEcCtD
Ketorolac—Headache—Gemcitabine—kidney cancer	5.78e-05	0.000217	CcSEcCtD
Ketorolac—Nausea—Vincristine—kidney cancer	5.78e-05	0.000217	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.78e-05	0.000217	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—kidney cancer	5.77e-05	0.000216	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—kidney cancer	5.75e-05	0.000216	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—kidney cancer	5.75e-05	0.000216	CcSEcCtD
Ketorolac—Insomnia—Capecitabine—kidney cancer	5.74e-05	0.000215	CcSEcCtD
Ketorolac—Paraesthesia—Capecitabine—kidney cancer	5.69e-05	0.000214	CcSEcCtD
Ketorolac—Hypersensitivity—Paclitaxel—kidney cancer	5.69e-05	0.000214	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—kidney cancer	5.68e-05	0.000213	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—kidney cancer	5.65e-05	0.000212	CcSEcCtD
Ketorolac—Dyspnoea—Capecitabine—kidney cancer	5.65e-05	0.000212	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—kidney cancer	5.64e-05	0.000212	CcSEcCtD
Ketorolac—PTGS2—Disease—CCBL1—kidney cancer	5.58e-05	0.00201	CbGpPWpGaD
Ketorolac—Dyspepsia—Capecitabine—kidney cancer	5.58e-05	0.000209	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—kidney cancer	5.54e-05	0.000208	CcSEcCtD
Ketorolac—Asthenia—Paclitaxel—kidney cancer	5.54e-05	0.000208	CcSEcCtD
Ketorolac—Decreased appetite—Capecitabine—kidney cancer	5.51e-05	0.000207	CcSEcCtD
Ketorolac—Nausea—Gemcitabine—kidney cancer	5.48e-05	0.000206	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Capecitabine—kidney cancer	5.47e-05	0.000205	CcSEcCtD
Ketorolac—Fatigue—Capecitabine—kidney cancer	5.47e-05	0.000205	CcSEcCtD
Ketorolac—Pruritus—Paclitaxel—kidney cancer	5.47e-05	0.000205	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—kidney cancer	5.44e-05	0.000204	CcSEcCtD
Ketorolac—Constipation—Capecitabine—kidney cancer	5.42e-05	0.000203	CcSEcCtD
Ketorolac—Pain—Capecitabine—kidney cancer	5.42e-05	0.000203	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—kidney cancer	5.38e-05	0.000202	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—kidney cancer	5.36e-05	0.000201	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—kidney cancer	5.34e-05	0.0002	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—kidney cancer	5.34e-05	0.0002	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.33e-05	0.00192	CbGpPWpGaD
Ketorolac—Diarrhoea—Paclitaxel—kidney cancer	5.29e-05	0.000198	CcSEcCtD
Ketorolac—Feeling abnormal—Capecitabine—kidney cancer	5.23e-05	0.000196	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—kidney cancer	5.22e-05	0.000196	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—kidney cancer	5.2e-05	0.000195	CcSEcCtD
Ketorolac—Gastrointestinal pain—Capecitabine—kidney cancer	5.19e-05	0.000194	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—kidney cancer	5.19e-05	0.000194	CcSEcCtD
Ketorolac—Chills—Doxorubicin—kidney cancer	5.16e-05	0.000194	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—kidney cancer	5.14e-05	0.000193	CcSEcCtD
Ketorolac—Dizziness—Paclitaxel—kidney cancer	5.11e-05	0.000192	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PPAT—kidney cancer	5.11e-05	0.00184	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GLIPR1—kidney cancer	5.11e-05	0.00184	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	5.09e-05	0.00183	CbGpPWpGaD
Ketorolac—Alopecia—Doxorubicin—kidney cancer	5.08e-05	0.000191	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	5.06e-05	0.00182	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AMER1—kidney cancer	5.05e-05	0.00182	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.04e-05	0.00182	CbGpPWpGaD
Ketorolac—Mental disorder—Doxorubicin—kidney cancer	5.04e-05	0.000189	CcSEcCtD
Ketorolac—Urticaria—Capecitabine—kidney cancer	5.04e-05	0.000189	CcSEcCtD
Ketorolac—Body temperature increased—Capecitabine—kidney cancer	5.01e-05	0.000188	CcSEcCtD
Ketorolac—Abdominal pain—Capecitabine—kidney cancer	5.01e-05	0.000188	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—kidney cancer	5.01e-05	0.000188	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—kidney cancer	5.01e-05	0.000188	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.99e-05	0.0018	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PDHB—kidney cancer	4.97e-05	0.00179	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL2—kidney cancer	4.96e-05	0.00178	CbGpPWpGaD
Ketorolac—Flatulence—Doxorubicin—kidney cancer	4.94e-05	0.000185	CcSEcCtD
Ketorolac—Tension—Doxorubicin—kidney cancer	4.92e-05	0.000184	CcSEcCtD
Ketorolac—Vomiting—Paclitaxel—kidney cancer	4.91e-05	0.000184	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—kidney cancer	4.9e-05	0.000184	CcSEcCtD
Ketorolac—Rash—Paclitaxel—kidney cancer	4.87e-05	0.000183	CcSEcCtD
Ketorolac—Dermatitis—Paclitaxel—kidney cancer	4.87e-05	0.000183	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—kidney cancer	4.86e-05	0.000182	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—kidney cancer	4.84e-05	0.000182	CcSEcCtD
Ketorolac—Headache—Paclitaxel—kidney cancer	4.84e-05	0.000182	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	4.83e-05	0.00174	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.79e-05	0.00172	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—APRT—kidney cancer	4.75e-05	0.00171	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FH—kidney cancer	4.75e-05	0.00171	CbGpPWpGaD
Ketorolac—Vision blurred—Doxorubicin—kidney cancer	4.72e-05	0.000177	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	4.7e-05	0.00169	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CCBL1—kidney cancer	4.68e-05	0.00168	CbGpPWpGaD
Ketorolac—Hypersensitivity—Capecitabine—kidney cancer	4.67e-05	0.000175	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—kidney cancer	4.65e-05	0.000174	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.64e-05	0.00167	CbGpPWpGaD
Ketorolac—Anaemia—Doxorubicin—kidney cancer	4.63e-05	0.000174	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—kidney cancer	4.6e-05	0.000173	CcSEcCtD
Ketorolac—Nausea—Paclitaxel—kidney cancer	4.59e-05	0.000172	CcSEcCtD
Ketorolac—Asthenia—Capecitabine—kidney cancer	4.55e-05	0.000171	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—kidney cancer	4.52e-05	0.000169	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—kidney cancer	4.5e-05	0.000169	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—kidney cancer	4.49e-05	0.000168	CcSEcCtD
Ketorolac—Pruritus—Capecitabine—kidney cancer	4.49e-05	0.000168	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—kidney cancer	4.48e-05	0.000168	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GPC3—kidney cancer	4.46e-05	0.00161	CbGpPWpGaD
Ketorolac—Palpitations—Doxorubicin—kidney cancer	4.43e-05	0.000166	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—kidney cancer	4.4e-05	0.000165	CcSEcCtD
Ketorolac—Cough—Doxorubicin—kidney cancer	4.37e-05	0.000164	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CA2—kidney cancer	4.34e-05	0.00156	CbGpPWpGaD
Ketorolac—Convulsion—Doxorubicin—kidney cancer	4.34e-05	0.000163	CcSEcCtD
Ketorolac—Diarrhoea—Capecitabine—kidney cancer	4.34e-05	0.000163	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—kidney cancer	4.32e-05	0.000162	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—kidney cancer	4.26e-05	0.00016	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—kidney cancer	4.26e-05	0.00016	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—kidney cancer	4.26e-05	0.00016	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—kidney cancer	4.25e-05	0.000159	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.23e-05	0.000159	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ALAD—kidney cancer	4.23e-05	0.00152	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GPC3—kidney cancer	4.23e-05	0.00152	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.23e-05	0.00152	CbGpPWpGaD
Ketorolac—Discomfort—Doxorubicin—kidney cancer	4.21e-05	0.000158	CcSEcCtD
Ketorolac—Dizziness—Capecitabine—kidney cancer	4.19e-05	0.000157	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—kidney cancer	4.17e-05	0.000156	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.13e-05	0.00149	CbGpPWpGaD
Ketorolac—Confusional state—Doxorubicin—kidney cancer	4.12e-05	0.000155	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—kidney cancer	4.09e-05	0.000153	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—kidney cancer	4.09e-05	0.000153	CcSEcCtD
Ketorolac—Infection—Doxorubicin—kidney cancer	4.06e-05	0.000152	CcSEcCtD
Ketorolac—PTGS2—Metabolism—PPAT—kidney cancer	4.06e-05	0.00146	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GLIPR1—kidney cancer	4.06e-05	0.00146	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.04e-05	0.00145	CbGpPWpGaD
Ketorolac—Vomiting—Capecitabine—kidney cancer	4.03e-05	0.000151	CcSEcCtD
Ketorolac—Shock—Doxorubicin—kidney cancer	4.02e-05	0.000151	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—kidney cancer	4.01e-05	0.00015	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4e-05	0.00144	CbGpPWpGaD
Ketorolac—Thrombocytopenia—Doxorubicin—kidney cancer	4e-05	0.00015	CcSEcCtD
Ketorolac—Rash—Capecitabine—kidney cancer	4e-05	0.00015	CcSEcCtD
Ketorolac—Dermatitis—Capecitabine—kidney cancer	3.99e-05	0.00015	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—kidney cancer	3.99e-05	0.00015	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.98e-05	0.00143	CbGpPWpGaD
Ketorolac—Headache—Capecitabine—kidney cancer	3.97e-05	0.000149	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—kidney cancer	3.97e-05	0.000149	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.96e-05	0.00143	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Doxorubicin—kidney cancer	3.95e-05	0.000148	CcSEcCtD
Ketorolac—PTGS2—Disease—ST3GAL2—kidney cancer	3.92e-05	0.00141	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—kidney cancer	3.9e-05	0.000146	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.88e-05	0.00139	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC5A3—kidney cancer	3.87e-05	0.00139	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PGK1—kidney cancer	3.87e-05	0.00139	CbGpPWpGaD
Ketorolac—Hypotension—Doxorubicin—kidney cancer	3.82e-05	0.000143	CcSEcCtD
Ketorolac—PTGS1—Metabolism—LDHB—kidney cancer	3.8e-05	0.00137	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.79e-05	0.00136	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—APRT—kidney cancer	3.77e-05	0.00136	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FH—kidney cancer	3.77e-05	0.00136	CbGpPWpGaD
Ketorolac—Nausea—Capecitabine—kidney cancer	3.77e-05	0.000141	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.76e-05	0.00135	CbGpPWpGaD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.72e-05	0.00014	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.72e-05	0.00134	CbGpPWpGaD
Ketorolac—Insomnia—Doxorubicin—kidney cancer	3.7e-05	0.000139	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.68e-05	0.00133	CbGpPWpGaD
Ketorolac—Paraesthesia—Doxorubicin—kidney cancer	3.67e-05	0.000138	CcSEcCtD
Ketorolac—PTGS2—Disease—SLC5A3—kidney cancer	3.67e-05	0.00132	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PGK1—kidney cancer	3.67e-05	0.00132	CbGpPWpGaD
Ketorolac—Dyspnoea—Doxorubicin—kidney cancer	3.64e-05	0.000137	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—kidney cancer	3.63e-05	0.000136	CcSEcCtD
Ketorolac—PTGS2—Disease—LDHB—kidney cancer	3.6e-05	0.0013	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SFRP2—kidney cancer	3.6e-05	0.0013	CbGpPWpGaD
Ketorolac—Dyspepsia—Doxorubicin—kidney cancer	3.6e-05	0.000135	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—kidney cancer	3.55e-05	0.000133	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GPC3—kidney cancer	3.54e-05	0.00128	CbGpPWpGaD
Ketorolac—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.53e-05	0.000132	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—kidney cancer	3.52e-05	0.000132	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—kidney cancer	3.5e-05	0.000131	CcSEcCtD
Ketorolac—Pain—Doxorubicin—kidney cancer	3.5e-05	0.000131	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CA2—kidney cancer	3.45e-05	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.44e-05	0.00124	CbGpPWpGaD
Ketorolac—Feeling abnormal—Doxorubicin—kidney cancer	3.37e-05	0.000126	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ALAD—kidney cancer	3.36e-05	0.00121	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TCEB1—kidney cancer	3.36e-05	0.00121	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TCEB2—kidney cancer	3.36e-05	0.00121	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Doxorubicin—kidney cancer	3.34e-05	0.000125	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CA9—kidney cancer	3.29e-05	0.00118	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.29e-05	0.00118	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.28e-05	0.00118	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.28e-05	0.00118	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.25e-05	0.00117	CbGpPWpGaD
Ketorolac—Urticaria—Doxorubicin—kidney cancer	3.25e-05	0.000122	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—kidney cancer	3.23e-05	0.000121	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—kidney cancer	3.23e-05	0.000121	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.22e-05	0.00116	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.21e-05	0.00115	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.18e-05	0.00115	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.17e-05	0.00114	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PGK1—kidney cancer	3.07e-05	0.00111	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC5A3—kidney cancer	3.07e-05	0.00111	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—LDHB—kidney cancer	3.01e-05	0.00108	CbGpPWpGaD
Ketorolac—Hypersensitivity—Doxorubicin—kidney cancer	3.01e-05	0.000113	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—kidney cancer	2.93e-05	0.00011	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—kidney cancer	2.89e-05	0.000108	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.87e-05	0.00103	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CRABP1—kidney cancer	2.8e-05	0.00101	CbGpPWpGaD
Ketorolac—Diarrhoea—Doxorubicin—kidney cancer	2.8e-05	0.000105	CcSEcCtD
Ketorolac—PTGS2—Disease—RPL14—kidney cancer	2.73e-05	0.000982	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.71e-05	0.000976	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—kidney cancer	2.7e-05	0.000101	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.64e-05	0.000949	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA9—kidney cancer	2.61e-05	0.000941	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ITPR2—kidney cancer	2.6e-05	0.000937	CbGpPWpGaD
Ketorolac—Vomiting—Doxorubicin—kidney cancer	2.6e-05	9.75e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.58e-05	0.000928	CbGpPWpGaD
Ketorolac—Rash—Doxorubicin—kidney cancer	2.58e-05	9.67e-05	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—kidney cancer	2.58e-05	9.66e-05	CcSEcCtD
Ketorolac—Headache—Doxorubicin—kidney cancer	2.56e-05	9.6e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.55e-05	0.000919	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ITPR2—kidney cancer	2.47e-05	0.000888	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.44e-05	0.000877	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—kidney cancer	2.43e-05	9.11e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.4e-05	0.000863	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—kidney cancer	2.37e-05	0.000854	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ACHE—kidney cancer	2.37e-05	0.000854	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SCARB1—kidney cancer	2.25e-05	0.000809	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.24e-05	0.000806	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CRABP1—kidney cancer	2.22e-05	0.0008	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSMD7—kidney cancer	2.18e-05	0.000785	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.16e-05	0.000779	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—BCHE—kidney cancer	2.07e-05	0.000744	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSMD7—kidney cancer	2.07e-05	0.000744	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ITPR2—kidney cancer	2.07e-05	0.000744	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC5A5—kidney cancer	2.04e-05	0.000735	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC2A1—kidney cancer	1.97e-05	0.00071	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.91e-05	0.000689	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.9e-05	0.000685	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—kidney cancer	1.88e-05	0.000678	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ACHE—kidney cancer	1.88e-05	0.000678	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SLC2A1—kidney cancer	1.87e-05	0.000673	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JUNB—kidney cancer	1.86e-05	0.000668	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SCARB1—kidney cancer	1.78e-05	0.000642	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTGS1—kidney cancer	1.77e-05	0.000635	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSMD7—kidney cancer	1.73e-05	0.000623	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.67e-05	0.000601	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—kidney cancer	1.64e-05	0.000592	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BCHE—kidney cancer	1.64e-05	0.000591	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC5A5—kidney cancer	1.62e-05	0.000583	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC2A1—kidney cancer	1.57e-05	0.000564	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCB1—kidney cancer	1.56e-05	0.00056	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—kidney cancer	1.51e-05	0.000544	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN2B—kidney cancer	1.51e-05	0.000544	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—kidney cancer	1.43e-05	0.000516	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.32e-05	0.000477	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—kidney cancer	1.31e-05	0.00047	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCB1—kidney cancer	1.24e-05	0.000445	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—kidney cancer	1.21e-05	0.000435	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TSC2—kidney cancer	1.2e-05	0.000434	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—kidney cancer	1.2e-05	0.000432	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.18e-05	0.000424	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—kidney cancer	1.14e-05	0.000409	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—POMC—kidney cancer	1.07e-05	0.000385	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KIT—kidney cancer	1.06e-05	0.000383	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—kidney cancer	1.06e-05	0.000383	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—kidney cancer	1e-05	0.00036	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.34e-06	0.000336	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—kidney cancer	8.52e-06	0.000307	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—POMC—kidney cancer	8.48e-06	0.000305	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RAF1—kidney cancer	8.35e-06	0.000301	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—kidney cancer	8.26e-06	0.000297	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTOR—kidney cancer	8.15e-06	0.000293	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD4—kidney cancer	8.14e-06	0.000293	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—kidney cancer	7.65e-06	0.000275	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—kidney cancer	7.43e-06	0.000267	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CTNNB1—kidney cancer	7.23e-06	0.00026	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—kidney cancer	7.04e-06	0.000254	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK3—kidney cancer	6.02e-06	0.000217	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—kidney cancer	5.9e-06	0.000212	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—kidney cancer	5.85e-06	0.000211	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK1—kidney cancer	5.73e-06	0.000206	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—kidney cancer	5.41e-06	0.000195	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—kidney cancer	5.24e-06	0.000189	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—kidney cancer	4.97e-06	0.000179	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—kidney cancer	4.16e-06	0.00015	CbGpPWpGaD
